Progress in therapy doesn’t mean always feeling good. Sometimes, it means finally feeling everything. Experiencing pain in ...

Thomas, PhD, CEO and founder of Metagenomi. “We made tremendous progress toward this goal in 2024, with accomplishments including substantially advancing MGX-001, our potentially curative ...

The company is actively evaluating opportunities to maximize the therapeutic potential of this program. Nimbus continues to progress drug discovery efforts across metabolic and autoimmune targets ...

Thomas, PhD, CEO and founder of Metagenomi. “We made tremendous progress toward this goal in 2024, with accomplishments including substantially advancing MGX-001, our potentially curative development ...

UNICEF-supported clinics provide essential health and nutrition services for displaced families struggling to survive.

Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025 SOUTH SAN FRANSCISCO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

After the session, an update can be generated to reflect the discussion’s key points, highlight therapeutic progress, and note follow-ups for future sessions. “At Talkspace, our goal is to ...

“The decision is unrelated to the therapeutic potential of microproteins, our platform and our scientific progress,” the biotech added in the Jan. 8 post. “We are optimistic that our efforts ...

Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...